On March 24, 2020 The biotechnology company focused on developing curative gene therapies for chronic systemic diseases reported that it has appointment of Julie Krop M.D. as Chief Medical Officer (CMO) with effect from 1st April 2020 (Press release, UCLB, MAR 24, 2020, View Source [SID1234555790]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!